Therapeutic Apheresis Market
Therapeutic Apheresis is the New Innovation in the Healthcare Industry. Get to Know the Key Insights
Therapeutic Apheresis Market by Product Type, Technique, End User & Region - Forecast 2022 - 2032
Therapeutic Apheresis Market Outlook (2022-2032)
[324 Pages Report] The demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period. The global therapeutic apheresis market share is projected to be valued at US$ 2577.9 Mn in 2022 and is expected to reach US$ 5313 Mn by 2032. The demand for therapeutic apheresis is surging owing to growing incidences of chronic diseases and an increasing number of trauma and injury cases.
Apheresis is a procedure wherein blood is withdrawn from a donor’s body, extraction of one or more blood components such as platelets, plasma, and white blood cells and transfusing of the remaining blood back into the donor during the procedure or at the end of it. Therapeutic apheresis is a process of removing blood components from a patient with apheresis technology.
|
Report Attribute |
Details |
|
Therapeutic Apheresis Market Value (2022) |
US$ 2577.9 Million |
|
Therapeutic Apheresis Market Anticipated Value (2032) |
US$ 5313 Million |
|
Therapeutic Apheresis Projected Growth Rate (2022-2032) |
6.8% |
Therapeutic apheresis is used for removing defective cells. It is also used for the treatment of conditions in which a component or a pathogenic substance in the blood causes morbidity.
Basically, there are three types of therapeutic apheresis procedures used, namely therapeutic plasma exchange (TPE), red blood cell exchange (RBCX) and cellular depletions. Therapeutic plasma exchange is the elimination of a huge volume of plasma from the patient and replacing the plasma with suitable fluids. TPE is commonly used for the treatment of autoimmune diseases or immune-mediated diseases or disorders.
TPE removes paraproteins, monoclonal antibiotics, antigen-antibody, and autoimmune antibody complexes. Therapeutic apheresis particularly removes the significant proportion of one or more components causing diseases.
Let us know your requirement to get
100% FREE customization
What Is Driving The Global Therapeutic Apheresis Market?
- Growing need for several blood components, increasing prevalence of accidents globally, and additional government initiatives toward blood donation are a few primary drivers accelerating the therapeutic apheresis market.
- The growing dominance of various therapeutic procedures such as fluid replacement therapy, red cell exchange, dendritic cells cancer therapy, car T cells therapy, and extracorporeal therapy are broadly stirring the growth rate of the global market.
- Escalating trauma and injury cases, growing cases of chronic diseases, rising need for blood components and more awareness pertaining to blood safety, favorable reimbursement policies, and growing number of complicated surgical procedures are all responsible for the lucrative growth of the market.
- Constantly increasing geriatric population coupled with increasing healthcare expenditure and growing use of therapeutic apheresis in treating cancer is likely to boost the growth of global therapeutic apheresis market.
Restraining Factors Hampering The Market Growth
- Therapeutic apheresis procedures, apheresis devices, and installing the apheresis devices are an expensive affair and therefore the high cost associated with these procedures is anticipated to obstruct the growth of the therapeutic apheresis market.
- Lack of awareness coupled with dearth of qualified specialists and problems associated with apheresis method is likely to suppress the global market expansion.
- Apheresis results in growing occurrence of several disorders and diseases such as growth of germ cell tumors from stem cells of the germ line and early embryo, Guillain-Barré syndrome, Paraproteinemia, Waldenstrom's macroglobulinemia, non-Hodgkin’s lymphoma, symptomatic myeloma, and many others are broadly hindering the growth of the market.
- Rental model’s installation of apheresis devices, strict donor recruitment criteria, and decreased blood donations using apheresis as a result of lack of awareness are likely to restrict the market further over the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystNorth America To Dominate The Therapeutic Apheresis Market
North America accounted for the largest share, i.e., 32.6% market share in the global therapeutic apheresis market. Factors like growing demand for plasma-derived medicines production and well-established healthcare infrastructure. This region has smooth accessibility to advanced blood collection technologies. It also has the presence of some of the significant apheresis companies in the region.
Additionally, reasons such as soaring initiatives by the government towards blood donation coupled with the rising need for blood components across the globe. Moreover, approval of the latest indications for apheresis treatment, such as acute disseminated encephalomyelitis, autoimmune haemolytic anaemia, and neonatal cardiac lupus, support the growth of the market in this region.
Europe Likely To Portray A Promising Market For Therapeutic Apheresis
Europe is accountable for 28.9% market share in the global therapeutic apheresis market, owing to the growing prevalence of blood disorders such as profuse bleeding and a decrease in platelet count.
This region witnessed increasing cases of chronic diseases such as autoimmune diseases and cancer, and also growing number of organ donors also is supporting the growth of the market in this region.
The escalation in the rate of occurrence of chronic diseases, growing necessity for plasma sources, additional activities considering blood safety and increasing number of complicated surgical procedures are also fuelling the Europe therapeutic apheresis market.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Start-Up Ecosystem In The Therapeutic Apheresis Market
In June 2022, BioCaptiva raised nearly $2.6 million in latest seed funding to additionally develop its BioCaptis instrument which is an apheresis-based cell-free DNA capture device for using liquid biopsy testing. The financial round was led by existing investor Archangels, joined Scottish Enterprise, Cancer Research Horizons, and novel investor Old College Capital.
Key Players Benchmarking The Therapeutic Apheresis Market
Some of the key players in the network security firewalls market are Asahi Kasei Medical Co., Haemonetics Corporation, Miltenyi Biotec, Cerus Corporation, Terumo BCT Inc., Fresenius Kabi USA, Terumo Bct, B. Braun Melsungen AG, Nikkiso Co. Ltd., Medica S.p.A., Baxter Healthcare Corporation, Kawasumi Laboratories Inc., and Therakos Incorporation.
| Who | Terumo Bct |
| When | July 2022 |
| Strategic Move | Terumo Blood and Cell Technologies, a medical technology company, and and Eliaz Therapeutics Inc., a medical device company, announced an exclusive collaboration to assist with fighting sepsis-induced acute kidney injury and Acute kidney injury by aiming on removal of an upstream inflammatory protein known as Galectin-3 from blood plasma. |
| Who | Fresenius Kabi |
| When | July 2022 |
| Strategic Move | Fresenius Kabi introduced Thiotepa for Injection, USP, in the United Sates. Thiotepa is a generic equivalent of Tepadina®, is the latest addition to the company’s injectable oncology portfolio – the most comprehensive in the industry. This injection is available immediately in solo-dose vials. It has several indications, which includes patients’ treatment with adenocarcinoma of the ovary or breast. |
| Who | Miltenyi Biotec |
| When | July 2022 |
| Strategic Move | Miltenyi Biotec, a global provider of products and services for cellular therapy and biomedical research announced the Class III certification of all its CliniMACS® Reagents for clinical-scale cell separation under the new European Regulation EU 2017/745 on medical devices. |
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 6.8% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2016-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in US$ Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
Key Segments Of The Therapeutic Apheresis Market
By Procedure Types:
- Therapeutic Plasma Exchange (TPE)
- Red Blood Cell Exchange (RBCX)
- Cellular Depletions
By Technology:
- Centrifugation
- Membrane filtration
By Application:
- Hematology
- Neurology
- Nephrology
- Rheumatology
- Oncology
- Others
By End User:
- Hospitals
- Blood banks
- Specialty clinics
By Region:
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Frequently Asked Questions
The growth outlook for the therapeutic apheresis market is predicted to advance at a CAGR of 6.8% from 2022 to 2032.
The North American region is anticipated to lead the therapeutic apheresis market during the forecast period.
The therapeutic apheresis market is likely to hold a valuation of US$ 5313 million by 2032.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Therapeutic Apheresis Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Procedure Types
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Procedure Types, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Procedure Types, 2022-2032
5.3.1. Therapeutic Plasma Exchange (TPE)
5.3.2. Red Blood Cell Exchange (RBCX)
5.3.3. Cellular Depletions
5.4. Y-o-Y Growth Trend Analysis By Procedure Types, 2017-2021
5.5. Absolute $ Opportunity Analysis By Procedure Types, 2022-2032
6. Global Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Technology
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032
6.3.1. Centrifugation
6.3.2. Membrane Filtration
6.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021
6.5. Absolute $ Opportunity Analysis By Technology, 2022-2032
7. Global Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
7.3.1. Hematology
7.3.2. Neurology
7.3.3. Rheumatology
7.3.4. Oncology
7.3.5. Others
7.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
7.5. Absolute $ Opportunity Analysis By Application, 2022-2032
8. Global Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
8.3.1. Hospitals
8.3.2. Blood Banks
8.3.3. Specialty Clinics
8.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
8.5. Absolute $ Opportunity Analysis By End User, 2022-2032
9. Global Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Procedure Types
10.2.3. By Technology
10.2.4. By Application
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Procedure Types
10.3.3. By Technology
10.3.4. By Application
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Procedure Types
11.2.3. By Technology
11.2.4. By Application
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Procedure Types
11.3.3. By Technology
11.3.4. By Application
11.3.5. By End User
11.4. Key Takeaways
12. Europe Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. U.K.
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Procedure Types
12.2.3. By Technology
12.2.4. By Application
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Procedure Types
12.3.3. By Technology
12.3.4. By Application
12.3.5. By End User
12.4. Key Takeaways
13. Asia Pacific Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.1.4. India
13.2.1.5. Malaysia
13.2.1.6. Singapore
13.2.1.7. Australia
13.2.1.8. New Zealand
13.2.1.9. Rest of APAC
13.2.2. By Procedure Types
13.2.3. By Technology
13.2.4. By Application
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Procedure Types
13.3.3. By Technology
13.3.4. By Application
13.3.5. By End User
13.4. Key Takeaways
14. MEA Therapeutic Apheresis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Procedure Types
14.2.3. By Technology
14.2.4. By Application
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Procedure Types
14.3.3. By Technology
14.3.4. By Application
14.3.5. By End User
14.4. Key Takeaways
15. Key Countries Therapeutic Apheresis Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Procedure Types
15.1.2.2. By Technology
15.1.2.3. By Application
15.1.2.4. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Procedure Types
15.2.2.2. By Technology
15.2.2.3. By Application
15.2.2.4. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Procedure Types
15.3.2.2. By Technology
15.3.2.3. By Application
15.3.2.4. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Procedure Types
15.4.2.2. By Technology
15.4.2.3. By Application
15.4.2.4. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Procedure Types
15.5.2.2. By Technology
15.5.2.3. By Application
15.5.2.4. By End User
15.6. U.K.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Procedure Types
15.6.2.2. By Technology
15.6.2.3. By Application
15.6.2.4. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Procedure Types
15.7.2.2. By Technology
15.7.2.3. By Application
15.7.2.4. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Procedure Types
15.8.2.2. By Technology
15.8.2.3. By Application
15.8.2.4. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Procedure Types
15.9.2.2. By Technology
15.9.2.3. By Application
15.9.2.4. By End User
15.10. China
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Procedure Types
15.10.2.2. By Technology
15.10.2.3. By Application
15.10.2.4. By End User
15.11. Japan
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Procedure Types
15.11.2.2. By Technology
15.11.2.3. By Application
15.11.2.4. By End User
15.12. South Korea
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Procedure Types
15.12.2.2. By Technology
15.12.2.3. By Application
15.12.2.4. By End User
15.13. Malaysia
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Procedure Types
15.13.2.2. By Technology
15.13.2.3. By Application
15.13.2.4. By End User
15.14. Singapore
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Procedure Types
15.14.2.2. By Technology
15.14.2.3. By Application
15.14.2.4. By End User
15.15. Australia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Procedure Types
15.15.2.2. By Technology
15.15.2.3. By Application
15.15.2.4. By End User
15.16. New Zealand
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Procedure Types
15.16.2.2. By Technology
15.16.2.3. By Application
15.16.2.4. By End User
15.17. GCC Countries
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Procedure Types
15.17.2.2. By Technology
15.17.2.3. By Application
15.17.2.4. By End User
15.18. South Africa
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Procedure Types
15.18.2.2. By Technology
15.18.2.3. By Application
15.18.2.4. By End User
15.19. Israel
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Procedure Types
15.19.2.2. By Technology
15.19.2.3. By Application
15.19.2.4. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Procedure Types
16.3.3. By Technology
16.3.4. By Application
16.3.5. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Miltenyi Biotec
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Fresenius Kabi USA
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Terumo Bct, Inc.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Baxter Healthcare Corporation
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Medica S.p.A.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Haemonetics Corporation
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Asahi Kasei Medical Co., Ltd
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Kaneka Corporation
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Kawasumi Laboratories Inc
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Cerus Corporation
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Therapeutic Apheresis Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 02: Global Therapeutic Apheresis Market Value (US$ Mn) Forecast by Procedure Types, 2017-2032
Table 03: Global Therapeutic Apheresis Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 04: Global Therapeutic Apheresis Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 05: Global Therapeutic Apheresis Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 06: North America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 07: North America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Procedure Types, 2017-2032
Table 08: North America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 09: North America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 10: North America Therapeutic Apheresis Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 11: Latin America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 12: Latin America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Procedure Types, 2017-2032
Table 13: Latin America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 14: Latin America Therapeutic Apheresis Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 15: Latin America Therapeutic Apheresis Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 16: Europe Therapeutic Apheresis Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: Europe Therapeutic Apheresis Market Value (US$ Mn) Forecast by Procedure Types, 2017-2032
Table 18: Europe Therapeutic Apheresis Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 19: Europe Therapeutic Apheresis Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 20: Europe Therapeutic Apheresis Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 21: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 22: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Forecast by Procedure Types, 2017-2032
Table 23: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 24: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 25: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 26: MEA Therapeutic Apheresis Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 27: MEA Therapeutic Apheresis Market Value (US$ Mn) Forecast by Procedure Types, 2017-2032
Table 28: MEA Therapeutic Apheresis Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 29: MEA Therapeutic Apheresis Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 30: MEA Therapeutic Apheresis Market Value (US$ Mn) Forecast by End User, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Therapeutic Apheresis Market Value (US$ Mn) by Procedure Types, 2022-2032
Figure 02: Global Therapeutic Apheresis Market Value (US$ Mn) by Technology, 2022-2032
Figure 03: Global Therapeutic Apheresis Market Value (US$ Mn) by Application, 2022-2032
Figure 04: Global Therapeutic Apheresis Market Value (US$ Mn) by End User, 2022-2032
Figure 05: Global Therapeutic Apheresis Market Value (US$ Mn) by Region, 2022-2032
Figure 06: Global Therapeutic Apheresis Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 07: Global Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 08: Global Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 09: Global Therapeutic Apheresis Market Value (US$ Mn) Analysis by Procedure Types, 2017-2032
Figure 10: Global Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Procedure Types, 2022-2032
Figure 11: Global Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Procedure Types, 2022-2032
Figure 12: Global Therapeutic Apheresis Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 13: Global Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 14: Global Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 15: Global Therapeutic Apheresis Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 16: Global Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 17: Global Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 18: Global Therapeutic Apheresis Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 19: Global Therapeutic Apheresis Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 20: Global Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 21: Global Therapeutic Apheresis Market Attractiveness by Procedure Types, 2022-2032
Figure 22: Global Therapeutic Apheresis Market Attractiveness by Technology, 2022-2032
Figure 23: Global Therapeutic Apheresis Market Attractiveness by Application, 2022-2032
Figure 24: Global Therapeutic Apheresis Market Attractiveness by End User, 2022-2032
Figure 25: Global Therapeutic Apheresis Market Attractiveness by Region, 2022-2032
Figure 26: North America Therapeutic Apheresis Market Value (US$ Mn) by Procedure Types, 2022-2032
Figure 27: North America Therapeutic Apheresis Market Value (US$ Mn) by Technology, 2022-2032
Figure 28: North America Therapeutic Apheresis Market Value (US$ Mn) by Application, 2022-2032
Figure 29: North America Therapeutic Apheresis Market Value (US$ Mn) by End User, 2022-2032
Figure 30: North America Therapeutic Apheresis Market Value (US$ Mn) by Country, 2022-2032
Figure 31: North America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 32: North America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 33: North America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 34: North America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Procedure Types, 2017-2032
Figure 35: North America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Procedure Types, 2022-2032
Figure 36: North America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Procedure Types, 2022-2032
Figure 37: North America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 38: North America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 39: North America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 40: North America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 41: North America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 42: North America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 43: North America Therapeutic Apheresis Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 44: North America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 45: North America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 46: North America Therapeutic Apheresis Market Attractiveness by Procedure Types, 2022-2032
Figure 47: North America Therapeutic Apheresis Market Attractiveness by Technology, 2022-2032
Figure 48: North America Therapeutic Apheresis Market Attractiveness by Application, 2022-2032
Figure 49: North America Therapeutic Apheresis Market Attractiveness by End User, 2022-2032
Figure 50: North America Therapeutic Apheresis Market Attractiveness by Country, 2022-2032
Figure 51: Latin America Therapeutic Apheresis Market Value (US$ Mn) by Procedure Types, 2022-2032
Figure 52: Latin America Therapeutic Apheresis Market Value (US$ Mn) by Technology, 2022-2032
Figure 53: Latin America Therapeutic Apheresis Market Value (US$ Mn) by Application, 2022-2032
Figure 54: Latin America Therapeutic Apheresis Market Value (US$ Mn) by End User, 2022-2032
Figure 55: Latin America Therapeutic Apheresis Market Value (US$ Mn) by Country, 2022-2032
Figure 56: Latin America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 57: Latin America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 58: Latin America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 59: Latin America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Procedure Types, 2017-2032
Figure 60: Latin America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Procedure Types, 2022-2032
Figure 61: Latin America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Procedure Types, 2022-2032
Figure 62: Latin America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 63: Latin America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 64: Latin America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 65: Latin America Therapeutic Apheresis Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 66: Latin America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 67: Latin America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 68: Latin America Therapeutic Apheresis Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 69: Latin America Therapeutic Apheresis Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 70: Latin America Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 71: Latin America Therapeutic Apheresis Market Attractiveness by Procedure Types, 2022-2032
Figure 72: Latin America Therapeutic Apheresis Market Attractiveness by Technology, 2022-2032
Figure 73: Latin America Therapeutic Apheresis Market Attractiveness by Application, 2022-2032
Figure 74: Latin America Therapeutic Apheresis Market Attractiveness by End User, 2022-2032
Figure 75: Latin America Therapeutic Apheresis Market Attractiveness by Country, 2022-2032
Figure 76: Europe Therapeutic Apheresis Market Value (US$ Mn) by Procedure Types, 2022-2032
Figure 77: Europe Therapeutic Apheresis Market Value (US$ Mn) by Technology, 2022-2032
Figure 78: Europe Therapeutic Apheresis Market Value (US$ Mn) by Application, 2022-2032
Figure 79: Europe Therapeutic Apheresis Market Value (US$ Mn) by End User, 2022-2032
Figure 80: Europe Therapeutic Apheresis Market Value (US$ Mn) by Country, 2022-2032
Figure 81: Europe Therapeutic Apheresis Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 82: Europe Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 83: Europe Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 84: Europe Therapeutic Apheresis Market Value (US$ Mn) Analysis by Procedure Types, 2017-2032
Figure 85: Europe Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Procedure Types, 2022-2032
Figure 86: Europe Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Procedure Types, 2022-2032
Figure 87: Europe Therapeutic Apheresis Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 88: Europe Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 89: Europe Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 90: Europe Therapeutic Apheresis Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 91: Europe Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 92: Europe Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 93: Europe Therapeutic Apheresis Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 94: Europe Therapeutic Apheresis Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 95: Europe Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 96: Europe Therapeutic Apheresis Market Attractiveness by Procedure Types, 2022-2032
Figure 97: Europe Therapeutic Apheresis Market Attractiveness by Technology, 2022-2032
Figure 98: Europe Therapeutic Apheresis Market Attractiveness by Application, 2022-2032
Figure 99: Europe Therapeutic Apheresis Market Attractiveness by End User, 2022-2032
Figure 100: Europe Therapeutic Apheresis Market Attractiveness by Country, 2022-2032
Figure 101: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) by Procedure Types, 2022-2032
Figure 102: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) by Technology, 2022-2032
Figure 103: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) by Application, 2022-2032
Figure 104: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) by End User, 2022-2032
Figure 105: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) by Country, 2022-2032
Figure 106: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 107: Asia Pacific Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 108: Asia Pacific Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 109: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Analysis by Procedure Types, 2017-2032
Figure 110: Asia Pacific Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Procedure Types, 2022-2032
Figure 111: Asia Pacific Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Procedure Types, 2022-2032
Figure 112: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 113: Asia Pacific Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 114: Asia Pacific Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 115: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 116: Asia Pacific Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 117: Asia Pacific Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 118: Asia Pacific Therapeutic Apheresis Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 119: Asia Pacific Therapeutic Apheresis Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 120: Asia Pacific Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 121: Asia Pacific Therapeutic Apheresis Market Attractiveness by Procedure Types, 2022-2032
Figure 122: Asia Pacific Therapeutic Apheresis Market Attractiveness by Technology, 2022-2032
Figure 123: Asia Pacific Therapeutic Apheresis Market Attractiveness by Application, 2022-2032
Figure 124: Asia Pacific Therapeutic Apheresis Market Attractiveness by End User, 2022-2032
Figure 125: Asia Pacific Therapeutic Apheresis Market Attractiveness by Country, 2022-2032
Figure 126: MEA Therapeutic Apheresis Market Value (US$ Mn) by Procedure Types, 2022-2032
Figure 127: MEA Therapeutic Apheresis Market Value (US$ Mn) by Technology, 2022-2032
Figure 128: MEA Therapeutic Apheresis Market Value (US$ Mn) by Application, 2022-2032
Figure 129: MEA Therapeutic Apheresis Market Value (US$ Mn) by End User, 2022-2032
Figure 130: MEA Therapeutic Apheresis Market Value (US$ Mn) by Country, 2022-2032
Figure 131: MEA Therapeutic Apheresis Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 132: MEA Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 133: MEA Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 134: MEA Therapeutic Apheresis Market Value (US$ Mn) Analysis by Procedure Types, 2017-2032
Figure 135: MEA Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Procedure Types, 2022-2032
Figure 136: MEA Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Procedure Types, 2022-2032
Figure 137: MEA Therapeutic Apheresis Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 138: MEA Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 139: MEA Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 140: MEA Therapeutic Apheresis Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 141: MEA Therapeutic Apheresis Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 142: MEA Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 143: MEA Therapeutic Apheresis Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 144: MEA Therapeutic Apheresis Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 145: MEA Therapeutic Apheresis Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 146: MEA Therapeutic Apheresis Market Attractiveness by Procedure Types, 2022-2032
Figure 147: MEA Therapeutic Apheresis Market Attractiveness by Technology, 2022-2032
Figure 148: MEA Therapeutic Apheresis Market Attractiveness by Application, 2022-2032
Figure 149: MEA Therapeutic Apheresis Market Attractiveness by End User, 2022-2032
Figure 150: MEA Therapeutic Apheresis Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
